{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:05:15Z","timestamp":1792800315338,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","ejcancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.ejca.2015.11.013","type":"journal-article","created":{"date-parts":[[2015,12,22]],"date-time":"2015-12-22T19:02:22Z","timestamp":1450810942000},"page":"49-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Multiparameter flow cytometry is instrumental to distinguish myelodysplastic syndromes from non-neoplastic cytopenias"],"prefix":"10.1016","volume":"54","author":[{"given":"Eline M.P.","family":"Cremers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresia M.","family":"Westers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canan","family":"Alhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Cali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u00eblle J.","family":"Wondergem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pino J.","family":"Poddighe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gert J.","family":"Ossenkoppele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjan A.","family":"van de Loosdrecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2015.11.013_bib1","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1182\/blood.V89.6.2079","article-title":"International scoring system for evaluating prognosis in myelodysplastic syndromes","volume":"89","author":"Greenberg","year":"1997","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2015.11.013_bib2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2141.1982.tb08475.x","article-title":"Proposals for the classification of the myelodysplastic syndromes","volume":"51","author":"Bennett","year":"1982","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ejca.2015.11.013_bib3","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1182\/blood-2002-04-1199","article-title":"The World Health Organization (WHO) classification of the myeloid neoplasms","volume":"100","author":"Vardiman","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2015.11.013_bib4","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1182\/blood-2009-03-209262","article-title":"The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes","volume":"114","author":"Vardiman","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2015.11.013_bib5","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1056\/NEJMra0902908","article-title":"Myelodysplastic syndromes","volume":"361","author":"Tefferi","year":"2009","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ejca.2015.11.013_bib6","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1016\/j.leukres.2013.10.007","article-title":"Current pathology practices in and barriers to MDS diagnosis","volume":"37","author":"Glauser","year":"2013","journal-title":"Leuk Res"},{"key":"10.1016\/j.ejca.2015.11.013_bib7","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1200\/JCO.2011.35.6394","article-title":"New comprehensive cytogenetic scoring system for primary myelodysplastic syndromes (MDS) and oligoblastic acute myeloid leukemia after MDS derived from an international database merge","volume":"30","author":"Schanz","year":"2012","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"10.1016\/j.ejca.2015.11.013_bib8","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1182\/blood-2007-03-082404","article-title":"New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients","volume":"110","author":"Haase","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2015.11.013_bib9","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.leukres.2012.08.008","article-title":"The classification of MDS: from FAB to WHO and beyond","volume":"36","author":"Vardiman","year":"2012","journal-title":"Leuk Res"},{"key":"10.1016\/j.ejca.2015.11.013_bib10","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.5858\/2008-132-1329-LOTYCA","article-title":"Loss of the Y chromosome an age-related or clonal phenomenon in acute myelogenous","author":"Wong","year":"2008","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.ejca.2015.11.013_bib11","first-page":"1","article-title":"Diagnosis and treatment of primary myelodysplastic syndromes in adults: recommendations from the European LeukemiaNet","author":"Malcovati","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2015.11.013_bib12","doi-asserted-by":"crossref","first-page":"201","DOI":"10.3324\/haematol.2012.066787","article-title":"Serial assessment of suspected myelodysplastic syndromes: significance of flow cytometric findings validated by cytomorphology, cytogenetics, and molecular genetics","volume":"98","author":"Kern","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.ejca.2015.11.013_bib13","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.leukres.2006.11.009","article-title":"Definitions and standards in the diagnosis and treatment of the myelodysplastic syndromes: consensus statements and report from a working conference","volume":"31","author":"Valent","year":"2007","journal-title":"Leuk Res"},{"key":"10.1016\/j.ejca.2015.11.013_bib14","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3324\/haematol.2009.008532","article-title":"Diagnostic utility of flow cytometry in low-grade myelodysplastic syndromes: a prospective validation study","volume":"94","author":"Ogata","year":"2009","journal-title":"Haematologica"},{"key":"10.1016\/j.ejca.2015.11.013_bib15","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1182\/blood-2002-09-2768","article-title":"Myeloid and monocytic dyspoiesis as determined by flow cytometric scoring in myelodysplastic syndrome correlates with the IPSS and with outcome after hematopoietic stem cell transplantation","volume":"102","author":"Wells","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2015.11.013_bib16","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/cyto.b.20582","article-title":"Phenotypic abnormalities strongly reflect genotype in patients with unexplained cytopenias","volume":"80","author":"Cutler","year":"2011","journal-title":"Cytom Part B Clin Cytom"},{"key":"10.1016\/j.ejca.2015.11.013_bib17","doi-asserted-by":"crossref","first-page":"892","DOI":"10.6004\/jnccn.2013.0106","article-title":"Cutting edge: flow cytometry in myelodysplastic syndromes","volume":"11","author":"Van de Loosdrecht","year":"2013","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.ejca.2015.11.013_bib18","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1038\/leu.2012.30","article-title":"Standardization of flow cytometry in myelodysplastic syndromes: a report from an international consortium and the European LeukemiaNet Working Group","volume":"26","author":"Westers","year":"2012","journal-title":"Leuk Off J Leuk Soc Am Leuk Res Fund UK"},{"key":"10.1016\/j.ejca.2015.11.013_bib19","article-title":"Flow cytometry immunophenotypic findings in chronic myelomonocytic leukemia and its utility in monitoring treatment response","author":"Shen","year":"2014","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.ejca.2015.11.013_bib20","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cancergencyto.2010.02.005","article-title":"Genetic analysis of dasatinib-treated chronic myeloid leukemia rapidly developing into acute myeloid leukemia with monosomy 7 in Philadelphia-negative cells","volume":"199","author":"Larsson","year":"2010","journal-title":"Cancer Gen Cytogenet"},{"key":"10.1016\/j.ejca.2015.11.013_bib21","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1002\/cncr.25353","article-title":"Clinical utility of multiparameter flow cytometry in the diagnosis of 1013 patients with suspected myelodysplastic syndrome: correlation to cytomorphology, cytogenetics, and clinical data","volume":"116","author":"Kern","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2015.11.013_bib22","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.leukres.2009.01.012","article-title":"The utility of flow cytometric immunophenotyping in cytopenic patients with a non-diagnostic bone marrow: a prospective study","volume":"33","author":"Truong","year":"2009","journal-title":"Leuk Res"},{"key":"10.1016\/j.ejca.2015.11.013_bib23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.leukres.2007.06.012","article-title":"Flow cytometric analysis of myelomonocytic cells by a pattern recognition approach is sensitive and specific in diagnosing myelodysplastic syndrome and related marrow diseases: emphasis on a global evaluation and recognition of diagnostic pitfalls","volume":"32","author":"Stachurski","year":"2008","journal-title":"Leuk Res"},{"key":"10.1016\/j.ejca.2015.11.013_bib24","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.3324\/haematol.2011.048421","article-title":"Multicenter validation of a reproducible flow cytometric score for the diagnosis of low-grade myelodysplastic syndromes: results of a European LeukemiaNET study","volume":"97","author":"Della Porta","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.ejca.2015.11.013_bib25","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1038\/leu.2013.178","article-title":"Flow cytometric detection of dyserythropoiesis: a sensitive and powerful diagnostic tool for myelodysplastic syndromes","volume":"27","author":"Mathis","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.ejca.2015.11.013_bib26","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1182\/blood-2012-03-420489","article-title":"Revised international prognostic scoring system for myelodysplastic syndromes","volume":"120","author":"Greenberg","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.ejca.2015.11.013_bib27","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.leukres.2007.03.015","article-title":"Idiopathic cytopenia of undetermined significance (ICUS) versus low risk MDS: the diagnostic interface","volume":"31","author":"Wimazal","year":"2007","journal-title":"Leuk Res"},{"key":"10.1016\/j.ejca.2015.11.013_bib28","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1111\/j.1365-2362.2009.02151.x","article-title":"Minimal diagnostic criteria for myelodysplastic syndromes and separation from ICUS and IDUS: update and open questions","volume":"39","author":"Valent","year":"2009","journal-title":"Eur J Clin Investig"},{"key":"10.1016\/j.ejca.2015.11.013_bib29","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1182\/blood-2013-08-518886","article-title":"Clinical and biological implications of driver mutations in myelodysplastic syndromes","volume":"122","author":"Papaemmanuil","year":"2013","journal-title":"Blood"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804915010436?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804915010436?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,30]],"date-time":"2022-05-30T12:02:13Z","timestamp":1653912133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804915010436"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":29,"alternative-id":["S0959804915010436"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2015.11.013","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiparameter flow cytometry is instrumental to distinguish myelodysplastic syndromes from non-neoplastic cytopenias","name":"articletitle","label":"Article Title"},{"value":"European Journal of Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejca.2015.11.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}